The present invention relates to 5-Aryltetrazole compounds, compositions
comprising a 5-Aryltetrazole compound, and methods for treating an
inflammation disease, a reperfusion disease, hyperuricemia, gout, or
tumor-lysis syndrome in an animal in need thereof comprising
administering to the animal an effective amount of a 5-Aryltetrazole
compound.